|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: EMA (2009), FDA (2011)) |
IUPAC Name ![]() |
| 5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 8457 | indacaterol |
Synonyms ![]() |
| Arcapta Neohaler® |
| Onbrez® |
| QAB-149 |
| QAB149 |
Database Links ![]() |
|
| CAS Registry No. | 312753-06-3 |
| ChEBI | CHEBI:68575 |
| ChEMBL Ligand | CHEMBL1095777 |
| DrugBank Ligand | DB05039 |
| PubChem CID | 6918554 |
| Search Google for chemical match using the InChIKey | QZZUEBNBZAPZLX-QFIPXVFZSA-N |
| Search Google for chemicals with the same backbone | QZZUEBNBZAPZLX |
| Search PubMed clinical trials | indacaterol |
| Search PubMed titles | indacaterol |
| Search PubMed titles/abstracts | indacaterol |
| Wikipedia | Indacaterol |
| Comments |
| Only the R-enantiomer, as the maleate salt (PubChem CID 9827599) is contained in the medicinal product. |